Results 271 to 280 of about 12,051,773 (333)

HLA-DR expression in cytotoxic T lymphocytes: a key to boost the therapeutic potential of T cell-based strategies for breast cancer. [PDF]

Front Immunol
Salvador R, Correia BF, Grosa D, Martins T, Soares Baal SC, Saraiva DP, Cristóvão-Ferreira S, Pereira IL, Rebelo de Almeida C, Fior R, Jacinto A, Mathias C, Braga S, Cabral MG.   +13 more
europepmc   +1 more source

Novel Experimental Approach to Investigate Immune Control of Vascular Function: Co-culture of Murine Aortas With T Lymphocytes or Macrophages. [PDF]

Bio Protoc
Kress TC, Barris CT, Kennard S, Belin de Chantemèle EJ.   +3 more
europepmc   +1 more source

Erratum to "Global Trends in Research of Amino Acid Metabolism in T Lymphocytes in Recent 15 Years: A Bibliometric Analysis". [PDF]

J Immunol Res
europepmc   +1 more source

T Lymphocyte Apoptosis in Systemic Lupus Erythematosus Patients

, 2013
Maryam Rastin, Mahmoud Mahmoudi, Mohammadreza Hatef, Maryam Sahebari, Nafiseh Tabasi, Dariush Haghmorad, Reza Nosratabadi, Mahdieh Khazaee, Mitra Masoudian, Shahrzad Zamani   +9 more
openalex   +1 more source

Isolation and biochemical characterization of a serine proteinase inhibitor from a HTLV-1-transformed established human T lymphocyte line.

D Cearlock
openalex  

Some of the next articles are maybe not open access.

Related searches:

T lymphocytes

The International Journal of Biochemistry & Cell Biology, 2003
T cells are major players in the adaptive immune response to pathogens. They express clonally distributed, highly polymorphic antigen receptors that enable them to recognize cell-associated antigen. Upon antigen recognition, T cells undergo clonal amplification and progressively acquire effector functions, ranging from the production of paracrine ...
FABBRI M, SMART C, PARDI , RUGGERO
openaire   +5 more sources

Imidazole-based Synthetic Lipidoids for In Vivo mRNA Delivery into Primary T Lymphocytes.

Angewandte Chemie, 2020
Engineering T lymphocytes is an emerging approach in a variety of biomedical applications. However, delivering large biologics to primary T lymphocytes directly in vivo is technically challenging due to the low transfection efficacy.
Xuewei Zhao, Jinjin Chen, Min Qiu, Yamin Li, Z. Glass, Qiaobing Xu   +5 more
semanticscholar   +1 more source